Connect Biopharma Holdings (CNTB) Other Non-Current Assets (2020 - 2026)

Connect Biopharma Holdings has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $646000.0 for Q2 2026.

• In Q2 2026, Other Non-Current Assets rose 1335.56% year-over-year to $646000.0; the TTM figure through Jun 2026 stood at $646000.0 (up 1335.56% YoY), while the FY2025 annual figure was $646000.0, up 1857.58% from the prior year.
• Other Non-Current Assets came in at $646000.0 for Q2 2026 at Connect Biopharma Holdings, roughly flat from $646000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $835000.0 in Q2 2022 to a low of $24000.0 in Q4 2023.
• Average Other Non-Current Assets over 5 years is $337051.6, with a median of $171309.8 recorded in 2022.
• Year-over-year, Other Non-Current Assets plunged 91.62% in 2022 and soared 1857.58% in 2025.
• Over 5 years, Other Non-Current Assets stood at $246619.6 in 2022, then slumped by 90.27% to $24000.0 in 2023, then surged by 37.5% to $33000.0 in 2024, then soared by 1857.58% to $646000.0 in 2025, then changed by 0.0% to $646000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $646000.0 in Q2 2026, $646000.0 in Q1 2026, and $646000.0 in Q4 2025.